These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension. Abid S, Houssaïni A, Mouraret N, Marcos E, Amsellem V, Wan F, Dubois-Randé JL, Derumeaux G, Boczkowski J, Motterlini R, Adnot S. Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871 [Abstract] [Full Text] [Related]
5. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Zhang L, Wang Y, Wu G, Rao L, Wei Y, Yue H, Yuan T, Yang P, Xiong F, Zhang S, Zhou Q, Chen Z, Li J, Mo BW, Zhang H, Xiong W, Wang CY. Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454 [Abstract] [Full Text] [Related]
6. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells. Xia S, Tai X, Wang Y, An X, Qian G, Dong J, Wang X, Sha B, Wang D, Murthi P, Kalionis B, Wang X, Bai C. Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044 [Abstract] [Full Text] [Related]
12. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats. Bordenave J, Thuillet R, Tu L, Phan C, Cumont A, Marsol C, Huertas A, Savale L, Hibert M, Galzi JL, Bonnet D, Humbert M, Frossard N, Guignabert C. Cardiovasc Res; 2020 Mar 01; 116(3):686-697. PubMed ID: 31173066 [Abstract] [Full Text] [Related]
13. PAI-1 deficiency drives pulmonary vascular smooth muscle remodeling and pulmonary hypertension. Kudryashova TV, Zaitsev SV, Jiang L, Buckley BJ, McGuckin JP, Goncharov D, Zhyvylo I, Lin D, Newcomb G, Piper B, Bogamuwa S, Saiyed A, Teos L, Pena A, Ranson M, Greenland JR, Wolters PJ, Kelso MJ, Poncz M, DeLisser HM, Cines DB, Goncharova EA, Farkas L, Stepanova V. Am J Physiol Lung Cell Mol Physiol; 2024 Sep 01; 327(3):L319-L326. PubMed ID: 38860847 [Abstract] [Full Text] [Related]
14. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. Chen YF, Feng JA, Li P, Xing D, Zhang Y, Serra R, Ambalavanan N, Majid-Hassan E, Oparil S. J Appl Physiol (1985); 2006 Feb 01; 100(2):564-71. PubMed ID: 16223981 [Abstract] [Full Text] [Related]
15. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment. Veith C, Zakrzewicz D, Dahal BK, Bálint Z, Murmann K, Wygrecka M, Seeger W, Schermuly RT, Weissmann N, Kwapiszewska G. Thromb Haemost; 2014 Dec 01; 112(6):1288-303. PubMed ID: 25231004 [Abstract] [Full Text] [Related]